key: cord-0018287-crlpzjk0
authors: Sankaran, Deepika; Zeinali, Lida; Iqbal, Sameeia; Chandrasekharan, Praveen; Lakshminrusimha, Satyan
title: Non-invasive carbon dioxide monitoring in neonates: methods, benefits, and pitfalls
date: 2021-06-19
journal: J Perinatol
DOI: 10.1038/s41372-021-01134-2
sha: e9cd226a12f2ea979da8c1f0243c2e6086e5c631
doc_id: 18287
cord_uid: crlpzjk0

Wide fluctuations in partial pressure of carbon dioxide (PaCO(2)) can potentially be associated with neurological and lung injury in neonates. Blood gas measurement is the gold standard for assessing gas exchange but is intermittent, invasive, and contributes to iatrogenic blood loss. Non-invasive carbon dioxide (CO(2)) monitoring has become ubiquitous in anesthesia and critical care and is being increasingly used in neonates. Two common methods of non-invasive CO(2) monitoring are end-tidal and transcutaneous. A colorimetric CO(2) detector (a modified end-tidal CO(2) detector) is recommended by the International Liaison Committee on Resuscitation (ILCOR) and the American Academy of Pediatrics to confirm endotracheal tube placement. Continuous CO(2) monitoring is helpful in trending PaCO(2) in critically ill neonates on respiratory support and can potentially lead to early detection and minimization of fluctuations in PaCO(2). This review includes a description of the various types of CO(2) monitoring and their applications, benefits, and limitations in neonates.

Arterial blood gas (ABG) measurement is the gold standard assessment of gas exchange. With the advent of pulse oximetry, continuous, non-invasive assessment of oxygenation is common practice and has been evaluated in multiple randomized controlled trials in preterm neonates [1, 2] . Non-invasive assessment of ventilation can be performed by end-tidal (EtCO 2 ) or transcutaneous (TCOM) monitoring of carbon dioxide (CO 2 ). Fluctuations in CO 2 lead to changes in cerebral and pulmonary blood flow and are associated with brain injury [3, 4] and severe intraventricular hemorrhage (IVH) in preterm infants [5] highlighting the importance of continuous monitoring. This article gives a brief overview of the history, methods, benefits, and pitfalls of both types of non-invasive CO 2 monitoring.

History of non-invasive carbon dioxide monitoring The CO 2 in exhaled gas is an indicator of changes in CO 2 production in the tissues, delivery to the lungs by the circulatory system, and elimination by the lungs. The term "capnography" is used to describe continuous graphic recording (capnogram) of the CO 2 concentration in respiratory gases [6] and can be plotted against time (time capnogram) or volume (volumetric capnogram) of gas. The instantaneous measurement and display of the CO 2 concentration are referred to as capnometry. Its early use dates back to World War II when it was utilized to monitor CO 2 concentrations inside submarines [7] .

Capnography was first illustrated by John Scott Haldane in the early 20th century when he built a gas analyzer [8] . A sample of gas at constant temperature and pressure would pass through a series of absorbents, and the concentration of CO 2 could be analyzed based on the reduction in the volume of gas.

Photoacoustic detection of sound generated by the pressure change resulting from infrared (IR) light passing through a gas sample [9] and the effect of ultraviolet and visible light on the rotational and vibrational energy of molecules that absorb it [10, 11] was also used to determine the concentration of CO 2 . Many decades after the first described CO 2 monitor [12] , Holland was the first country to adopt non-invasive CO 2 monitoring during anesthesia in the year 1978 [13, 14] . Shortly thereafter, it was introduced in the United States and became the gold standard in anesthesiology by the 1990s despite the lack of randomized controlled trials [15] . Since the advent of non-invasive CO 2 monitoring for clinical use, several improvisations have resulted in smaller, simpler, and lower-cost versions of exhaled CO 2 detectors/ monitors. Severinghaus in 1960 reported monitoring of CO 2 and O 2 during anesthesia using various methods including blood gas sampling, EtCO 2 monitoring, and "tissue" monitoring [16, 17] . Subsequently, he described transcutaneous monitoring by heating the skin to "arterialize" the sample [18] [19] [20] . The latest transcutaneous CO 2 monitors are based on the same principles.

Physiology of carbon dioxide monitoring Blood perfusing the pulmonary capillary bed is briefly exposed to the alveolar gas. During this short transit in healthy individuals, the PCO 2 decreases from~46 mmHg in the pulmonary arteriole to 40 mm Hg in the pulmonary venule by equilibrating with alveolar CO 2 (P A CO 2 ) [21, 22] . There is a high alveolar-to-atmospheric (atm) PCO 2 gradient of approximately 40 mmHg (P atm CO 2 is 0.3 mm Hg since CO 2 constitutes only 0.04% of the atmospheric air). Hence, PCO 2 is recorded as 0-1 mmHg during inspiration in the time capnogram (phase 0, Fig. 1 ). The exhaled CO 2 is measured by infrared spectroscopy (IR spectroscopy) as CO 2 absorbs and emits IR light in a distinct wavelength (4.26 µm).

The 4 phases noted in the CO 2 tracing include the following ( Fig. 1) :

Phase I: During exhalation, gas from the dead space containing minimal CO 2 is expired initially [23] .

Phase II: Subsequently, there is a dramatic increase in the exhaled CO 2 concentration (phase II), which then reaches a peak.

Phase III: The CO 2 concentration ultimately plateaus when all the exhaled gas originates from the alveoli. The initial part of phase III is a plateau due to the constant amount of CO 2 being emptied from the alveoli. The alveoli with lower ventilation/ perfusion (V/Q) ratios and longer time constant (i.e., more time to blow out CO 2 ) contribute to the latter part of phase III, causing a slight upward slope of the plateau phase (also called phase IV).

Phase IV: A terminal blip or upward slope (phase IV) may be observed at the end of phase III due to delayed emptying of the alveoli with a lesser quantity of exhaled air with higher CO 2 concentration. Beaking of phase IV is more common in lungs with poor compliance as in respiratory distress syndrome (RDS) (Fig. 1) [24] .

Substantial variation in the V/Q status of the alveoli can result in phase III being an extension of phase II (the slope of the plateau is increased and the α angle between phase II and III is altered from the usual angle of 100°) [24] . The maximum value of PCO 2 at the end of the breath is known as EtCO 2 . The CO 2 then quickly drops to zero at the end of phase III/IV, due to low levels of CO 2 in the inspired gas. The difference between the PaCO 2 and EtCO 2 is a marker of physiological dead space, with a difference of 5 mm Hg due to the mixing of alveolar CO 2 with the gas in the dead space without any CO 2 [25] . This difference is increased in the presence of lung disease such as bronchopulmonary dysplasia (BPD) [26] .

Types of non-invasive carbon dioxide monitoring Physical method (waveform capnography). Infrared (IR) spectrography evaluates the absorption of IR rays at a specific wavelength (0.43 µm) by CO 2 [27] . Hence, the quantity of CO 2 in respiratory gases can be measured by comparing the measured absorbance with that of a known standard and expressed as PCO 2 in mmHg.

1. Endotracheal/End tidal CO 2 (EtCO 2 ) monitoring: the capnograph sensor is connected to the endotracheal tube (ETT) and allows measurement and recording of EtCO 2 . These are further classified based on the location of the sensor (Table 1 and Fig. 2 ): (a) Main-stream sensor capnometer (Fig. 2) : The adaptor housing the sensor is connected as an attachment in between the Fig. 1 Time capnogram in which end-tidal CO 2 (EtCO 2 ) is traced against time. Phase I represents the gas from the anatomical and apparatus dead space and hence is CO 2 -free. Phase II has a rapid Sshaped upswing (mixing of alveolar gas with the dead space gas). Phase III or the alveolar plateau represents exhaled gas that is rich in CO 2 from the alveoli. Variation in the ventilation/ perfusion (V/Q) status of the alveoli can result in phase III being an extension of phase II. Phase IV or beaking is noted with respiratory distress syndrome (RDS) due to collapse and exhalation of alveolar gas. The change in the waveform in RDS, bronchopulmonary dysplasia (BPD), and esophageal intubation are also shown. The capnogram in BPD shows an exaggerated PaCO 2 -EtCO 2 gradient in BPD. PaCO 2 arterial partial pressure of carbon dioxide. Copyright Satyan Lakshminrusimha. Rapid ascertainment of ETT placement, especially in the delivery room during resuscitation.

False-negative in the setting of poor lung perfusion from low cardiac output, pulmonary hypoplasia, low tidal volumes, and air leak (Fig. 6 ).

PaCO 2 arterial partial pressure of carbon dioxide, EtCO 2 end-tidal CO 2 , TcPCO 2 transcutaneous CO 2, CO 2 carbon dioxide, V/Q ventilation/ perfusion ratio, CCDD colorimetric carbon dioxide detector. [28] . (b) Sidestream capnometer: The sensor is located in the main unit with a small pump that aspirates the patient's gas sample through capillary tubing from the proximal part of the ETT. Respiratory gas is then transported from the sampling tube to the IR measuring device causing a 1-4 s delay in PCO 2 measurement and display. Higher flow conventional sidestream capnography (150-200 ml/min) may cause underestimation of PCO 2 due to lower tidal volumes and higher respiratory rates in neonates [29] . However, microstream/low flow technique (50 ml/min) with a dead space of less than 0.5 ml improves the accuracy of sidestream capnography [30] [31] [32] . Sidestream capnography can also be used in infants on non-invasive ventilation and high-frequency ventilation [33] . (2) Transcutaneous CO 2 monitor (TCOM, Fig. 3 ): TCOM uses the principle of arterialization of cutaneous capillaries by application of heat [16] . The sensor consists of a glass pH electrode, a silver chloride reference electrode, a heating element, a temperature element, and an electrolyte reservoir. When the sensor (with a membrane covering the electrodes) is applied to the skin, heat is generated that causes vasodilation of cutaneous capillaries and increases the permeability of the skin to CO 2 . CO 2 that diffuses through the membrane reacts with water to form carbonic acid, which then dissociates into hydrogen and bicarbonate ions. This results in a change in pH that causes a potential difference between the two electrodes. Based on the linear relationship between pH and Log PCO 2 , the PCO 2 measurement (TcPCO 2 ) is obtained and is continuously recorded. The final recording corresponds to the PCO 2 in the cutaneous capillaries which has been shown to correlate well with PaCO 2 (between 20 and 74 mmHg), under stable hemodynamic conditions [34] .

The immature and thin epidermal layer in premature infants is advantageous for TcPCO 2 monitoring. Improved short-term respiratory outcomes were reported with TcPCO 2 monitoring during transport and during high-frequency oscillatory ventilation [35, 36] . Neonatal studies have shown that TcPCO 2 correlates better with PaCO 2 compared to EtCO 2 [37] [38] [39] . TcPCO 2 readings have been noted to be higher than PaCO 2 at higher temperatures owing to two proposed mechanisms: (a) higher solubility of CO 2 at higher temperatures (TcPCO 2 4.5% more than PaCO 2 ) [40] , and (b) additional CO 2 being produced from metabolism by the skin cells, and tissue diffusion. Preliminary studies during therapeutic hypothermia indicate that TcPCO 2 correlates well with PaCO 2 [41] .

Relative heating power (RHP, expressed in milliwatts or mW) is the power required to maintain the TcPCO 2 sensor at the set temperature [42] . A well-perfused baby will require a higher RHP than a poorly perfused baby to keep the sensor temperature stable in order to provide an accurate estimate of the PaCO 2 . In critically ill infants, the trend in RHP may be an indicator of the local blood flow. RHP may have potential application in an infant with ductal dependent systemic circulation (such as coarctation of the aorta or hypoplastic left heart syndrome). Any deviations from the RHPreference that is stored in the system will be displayed as positive or negative RHP values (considering 0 mW as the stored reference). Hence, interpreting TcPCO 2 along with the RHP (or local skin perfusion) is prudent.

Chemical method (colorimetric CO 2 detector). The principle underlying the effectiveness of the colorimetric CO 2 detector (CCDD) is the prevalence of low concentration of CO 2 in atmospheric air in the esophagus (0.03-0.04%) and high concentration of CO 2 in exhaled gas (4-5%) [43, 44] . A pHsensitive chemical indicator contained in a plastic apparatus is connected to the gas stream in between the ETT and the ventilator or source of positive pressure ventilation (PPV). Commercially available CCDD at present includes the Pedi-Cap® (Nellcor/Medtronic, Minneapolis MN) and Neo-StatCO 2 ® (Mercury Medical, Clearwater FL). These semi-quantitative single-use devices display a purple/blue color when CO 2 is low (0.03% to <0.5%) and turn yellow when the concentration approaches 5% [45] . The color changes with inspiration and expiration and from breath to breath, varying based on the CO 2 concentration. Although the Pedi-Cap® is not recommended for infants less than 1000 g, it is widely used to confirm ETT placement in neonates and in-vitro testing showed that it is effective at tidal volumes as small as~1 ml [46] [47] [48] [49] . The NeostatCO 2 ® device is suitable for infants 0.25-6 kg as per the manufacturer.

Detecting exhaled CO 2 with a CCDD along with a chest radiograph can confirm ETT placement in the respiratory tree; the CCDD is often instantaneously helpful in confirming placement in the delivery room (Fig. 4) [50] . A recent Cochrane review has shown insufficient evidence on the most effective technique to ascertain ETT placement in the delivery room or in the NICU and concluded that randomized trials are needed [51] . CCDD is a valuable adjunct to confirm ETT placement since an anteroposterior chest radiograph may miss esophageal intubation (Fig. 5) .

After non-invasive CO 2 monitoring became a standard of care during anesthesia, lawsuits born out of esophageal intubations and unexpected adverse events decreased and the premium to be paid by the anesthesiologists reduced drastically [24] . Widespread implementation of non-invasive CO 2 monitoring resulted in undetected esophageal intubation becoming a "never event" in the United Kingdom [52] . A prospective study from Europe showed a 66-fold higher chance of having an airway catastrophe in ICU when non-invasive CO 2 monitoring was not used [53] . Noninvasive CO 2 monitoring is currently used during procedural sedation, cardiopulmonary resuscitation, in the intensive care unit, during transportation on ventilators, in post-operative care, and in the emergency room. The American Heart Association (AHA) recommends the use of quantitative waveform capnography as a physiological feedback device to monitor the effectiveness of chest compressions (CC) and to detect the return of spontaneous circulation (ROSC, rapid rise in EtCO 2 to 35-45 mmHg) [54] . Sanders et al., have shown that EtCO 2 positively correlates with coronary perfusion pressure [55] . A prospective matched cohort study on adult in-hospital cardiac arrest (from AHA's Get With The Guidelines-Resuscitation registry) reported a higher likelihood of ROSC when EtCO 2 and diastolic blood pressure were monitored [56] .

In normal healthy newborns, the PaCO 2 is within the range of 35-45 mm Hg. Cerebral blood flow increases with hypercarbia and decreases with hypocarbia [57] [58] [59] . Both hypercarbia (17-30%) and hypocarbia (2.8-4%) are observed commonly among NICU patients [60, 61] . Continuous CO 2 monitoring could potentially decrease adverse outcomes in infants especially vulnerable to fluctuations in cerebral blood flow, such as preterm infants at risk for severe IVH, periventricular leukomalacia (PVL), and BPD, and infants with HIE [59, [62] [63] [64] [65] [66] . Managing the ventilator settings and choosing appropriate strategies to ventilate are often gleaned from continuous CO 2 monitoring in addition to bedside clinical evaluation. Intermittent assessments with blood gases come with the risk for periods of abnormally high or low PaCO 2 remaining unrecognized and corrective action being delayed.

(1) Use in delivery room during resuscitation.

(a) Mask ventilation: the CCDD serves as a simple tool with immediate feedback to qualify airway patency during mask ventilation in neonates [67] [68] [69] . In a single-center retrospective review of video recordings of face mask ventilation with a CCDD, CO 2 detection with CCDD preceded the rise in Sat ya n S a ty a n heart rate [45] . Clinical observational research in the use of CCDD during PPV with a facemask has advocated their use. Leone et al. described the benefits of CCDD when used with a facemask during PPV in the NICU [46] . In this study, during twenty-one instances of lack of color change on the CO 2 detector, twenty displayed a color change once the head/ jaw position was adjusted therefore allowing for easier determination of airway patency [46] . Similarly, van Os et al., showed that a CCDD enables a recognition of airway obstruction in very low birth weight infants during PPV [70] . A literature review by O'Reilly et al. elucidated that facemask leak and obstructions are more often than not unrecognized without the use of CCDD or respiratory function monitors (RM) [71] . However, the use of CCDD during PPV with a facemask has not been advocated in the International Liaison Committee on Resuscitation (ILCOR) guidelines [72] as there is limited data to support their use-therefore it is not routinely used in clinical settings. The overall recommendation for use of CCDD during facemask PPV has been labeled as level C (limited data) [73] . (b) ETT placement: the 2020 AHA and 2016 Neonatal resuscitation Program (NRP) guidelines recommend confirming ETT placement by CCDD or waveform capnography in intubated infants with a perfusing cardiac rhythm (Fig. 5 ) [74, 75] . CCDD is more accurate as well as quicker in confirming correct ETT placement when compared to clinical assessment [76, 77] . A retrospective analysis conducted by Roberts et al. found that time to recognition of esophageal placement using clinical indicators averaged 97.1 s compared to side-stream capnography (1.6 s) [78] . These findings corroborate the prospective study by Repetto et al. [79] comparing median time to CO 2 detection (9 s) with clinical assessment alone (30 s). Hawkes et al. reviewed studies that evaluated the use of a CCDD in confirming ETT placement and assessed them according to the AHA levels of evidence and grades of recommendation [73] . One such study investigated the Pedi-Cap®'s accuracy in conjunction with respiratory monitoring (RM) on a sample of 35 intubations and found that in 31% (11/35) intubations the Pedi-Cap® failed to change color despite correct ETT placement [80] . Based on current evidence, the recommendation for the use of a CCDD in confirming ETT placement in neonates is level B (moderate-quality evidence). It is possible that CCDD may miss esophageal intubation (false positive) or have a false negative reading despite the appropriate placement of the ETT (Fig. 6 ) [81] . (c) Chest compressions (CC): Non-invasive CO 2 monitoring as part of RM is of importance in adults during extensive resuscitation including CC to monitor the efficacy of the resuscitative interventions [82, 83] , and similar use in neonates as a feedback device is promising. In an ovine model of asphyxial arrest, continuous EtCO 2 monitoring predicted adequacy of CC and detection of ROSC [84] . Furthermore, in a large mammalian meconium aspiration model, continuous EtCO 2 monitoring limited fluctuation in PaCO 2 and cerebral blood flow during and after resuscitation [58] . The use of RM improved the effectiveness of newborn facemask ventilation training in a randomized trial with neonatal manikins [85] . Kong potentially enables us to detect expeditious changes in PaCO 2 especially in the first few hours after birth with rapid changes in lung compliance. This allows appropriate and timely adjustments in the ventilator, potentially avoiding prolonged exposure to hypo or hypercapnia, and decrease the duration of invasive ventilation. By avoiding rapid fluctuations in PaCO 2 (and hence cerebral blood flow), it may be protective against IVH, and improve long-term outcomes in extremely premature infants and infants with HIE (during and after therapeutic hypothermia) [59, [62] [63] [64] [65] [66] . Kugelman et al. performed a randomized multicenter study with EtCO 2 visible to the medical team for continuous monitoring in the experimental group and masked in the control group [88] . They observed that IVH and PVL were lower in the monitored group and continuous EtCO 2 monitoring improved the control of PaCO 2 within a safe range during conventional ventilation in the NICU. A good correlation has been observed between EtCO 2 and PaCO 2 in ventilated newborns [89] . The discrepancy between EtCO 2 and PaCO 2 increases with the increasing severity of lung disease and improves after surfactant administration. Nangia et al. observed a significant correlation between EtCO 2 and PaCO 2 in preterm infants <32 weeks gestation [90] . In another study involving 27 neonates <28 weeks gestation, Aliwalas et al. found only moderate agreement in the first 24 h after birth [91] . A retrospective study in extremely low birth weight (ELBW) infants showed a good correlation between EtCO 2 and PaCO 2 [92] . To summarize, EtCO 2 may be used as an adjunct to clinical assessment and PaCO 2 from ABGs, with caution exercised while relying solely on EtCO 2 from extremely preterm newborns (and those with severe lung disease) while making ventilatory adjustments. The ILCOR task force has removed the minimum weight of 20 kg for capnography and noted that continuous monitoring has become routine in many settings. (b) Minimize blood draws: The use of EtCO 2 and TCOM can decrease the need for repeated blood gases and iatrogenic blood losses in critically ill or preterm newborns who are prone to anemia. Although not as accurate as blood gases, they are reliable tools in measuring and trending PCO 2 in neonates [89, 93, 94] . CO 2 monitoring may potentially minimize blood draws in stable infants on non-invasive ventilation as well. (c) Monitoring during transport: TcPCO 2 has been shown to be more accurate when compared to EtCO 2 for monitoring ventilated neonates during transport [95] . In infants with a perfusing cardiac rhythm, it may be beneficial to monitor EtCO 2 either continuously or by frequent intermittent detection of exhaled CO 2 during out-of-hospital, intra-, or inter-hospital transport [74] . (d) Detect accidental extubation: Non-invasive CO 2 monitoring allows the trending of CO 2 among ill neonates in whom the baseline PaCO 2 is well established. A sudden change in the waveform (flattening, Fig. 1 [97] . Thus, EtCO 2 should not be solely relied upon while making ventilatory changes during surgery. Nevertheless, non-invasive CO 2 monitoring (especially TcPCO 2 ) may be helpful in postoperative management to assess the recovery of respiratory drive and alveolar ventilation after anesthesia.

There are several gaps that currently exist in our knowledge on neonatal non-invasive CO 2 monitoring ( Table 2 ). Some of the limitations of non-invasive CO 2 monitoring are listed below.

(a) Limitations of EtCO 2 monitoring: Despite being a useful adjunct to confirm ETT placement, detection of PaCO 2 by waveform capnography has been shown to miss esophageal intubation in 1 in 40 instances [98] . EtCO 2 has been used successfully even in ELBW infants. However, wide variation in EtCO 2 and poor correlation between EtCO 2 and PaCO 2 has been noted in critically ill preterm neonates. This is probably secondary to the V/Q mismatch in these newborns with more severe lung disease [31] . EtCO 2 measurements are expected to be lower than the PaCO 2 due to (i) intrapulmonary shunting with some of the arterial CO 2 bypassing the ventilated alveolar units, (ii) CO 2 being diluted in the conducting airways (anatomical dead space) that do not contribute to CO 2 production and (iii) portions of the lung that are ventilated but not perfused (alveolar dead space, that is increased in worsening lung disease). Inaccurate measurements owing to leakage around uncuffed ETT are not uncommon. The mainstream EtCO 2 monitor is bulky and adds to dead space, which may not be insignificant with the lower tidal volume being used to ventilate neonates. In addition, mainstream EtCO 2 monitoring cannot be performed in infants on non-invasive ventilation or high-frequency ventilation. Sidestream capnography, on the other hand, may underestimate the PaCO 2 due to low tidal volumes and rapid respiratory rates in newborns. High respiratory rates impede the formation of the alveolar plateau phase [99] . Furthermore, phase III of volumetric capnogram was steeper in infants with BPD, likely due to V/Q mismatch, leading to difficulty in differentiating phase II and III [100] . To overcome some of the limitations, sampling from a distal rather than a proximal site, minimizing the length of the tubing, and interpretation with caution for infants breathing at higher respiratory rates (>60 per minute) have been suggested [101] . In addition, distal EtCO 2 measured through a double-lumen ETT had a good correlation with PaCO 2 even in severe lung disease [28] . (b) Limitations with CCDD ( Fig. 6 ): There are several instances where a CCDD may be falsely negative (purple/blue), including low cardiac output, airway obstruction [48, 76, 77, 80, 102] , suboptimal tidal volumes (threshold > 0.72 ml) [48, 49] , incomplete exhalation, or an air leak (Fig. 4 ) [79] . When a fixed pressure is used during PPV, the delivered tidal volume is dependent on the infant's weight, presence of spontaneous breaths (and whether they are synchronized), compliance of the lungs and chest wall, airway resistance, and leak [48, 103] . Conversely, a CCDD may be falsely positive (yellow) with esophageal intubation when expired CO 2 has been forced into the stomach during prior mask ventilation, or during contamination of the colorimetric paper by gastric acid or epinephrine [104] . Bilateral pulmonary hypoplasia (usually due to prolonged oligohydramnios) can potentially limit the volume of exhaled CO 2 leading to false-negative CCDD. Therefore, CCDD readings may be misleading and it is crucial that they are interpreted in conjunction with clinical signs. (c) Limitations with TCOM: There have been reports of poor correlation with variation in TcPCO 2 in preterm and ill neonates [91, 105] . The device should be calibrated using known gas mixtures or the neonate's blood sample and should be corrected for the infant's temperature. The position of sensors should be changed every 4-12 h, depending on the operating temperature of the electrode and the condition of the infant's skin, per the manufacturer's instructions. The TcPCO 2 recording may be inaccurate in the Table 2 . Gaps in knowledge related to using non-invasive CO 2 monitoring in neonates.

End-tidal CO 2 monitoring (EtCO 2 ) Is EtCO 2 monitoring feasible during delivery room resuscitation of newborns? Can EtCO 2 monitoring be helpful in the delivery room to optimize neonatal ventilation and allow gentle ventilation? Can routine EtCO 2 monitoring help in detecting the return of spontaneous circulation in asphyxiated newborns undergoing resuscitation in the delivery room? Should respiratory function monitors with the ability to measure exhaled CO 2 , inflation pressure, tidal volume, and air leak around the mask, be routinely used in the delivery room?

Transcutaneous CO 2 monitoring (TcPCO 2 ) Is it safe, accurate, and reliable in extremely premature and ill neonates? Can TcPCO 2 be used to guide clinical decisions in neonates with hypoxic-ischemic encephalopathy undergoing therapeutic hypothermia? Is TcPCO 2 reliable and in agreement with PaCO 2 during surgery/ anesthesia in neonates? Can this technique be used to monitor tissue perfusion and cellular metabolic function? Can relative heating power be used to assess perfusion status?

Colorimetric carbon dioxide detectors (CCDD)

Can routine use with face mask ventilation in the delivery room be beneficial? Can corrective actions for improving the effectiveness of positive pressure ventilation be performed earlier if CCDD is routinely used with facemask ventilation? Can the current pitfalls (inaccuracy due to soiling with epinephrine/ secretions) be overcome? Are CCDD helpful in confirming the position of less invasive surfactant administration (LISA) catheters, and with laryngeal mask airways (LMA)?

PaCO 2 arterial partial pressure of carbon dioxide, EtCO 2 end-tidal CO 2 , TcPCO 2 transcutaneous CO 2 , CCDD colorimetric carbon dioxide detector.

D. Sankaran et al.

setting of improper placement, entrapped air bubbles, error in the equipment, or in calibration. In order to minimize burns secondary to the high electrode temperature in TCOM, lower electrode temperatures (38-39°C) have been successfully used with good accuracy after applying a bias correction of 12-15% [106, 107] . However, the main advantages of TCOM are (a) it minimizes the need for repeated blood sampling, (b) allows for trending PCO 2 over a period of time, (c) can be used with any type of ventilator and also in non-ventilated patients, and (d) can be reliably used during transport of ventilated newborns [95] .

In neonates, waveform capnography is widely applied in the NICU for monitoring of ventilated and critically ill term and preterm infants. In addition, both EtCO 2 and TcPCO 2 provide valuable input in managing infants during the transport of ventilated infants. The use of CCDD has become a standard in the delivery room, as an adjunct to clinical assessment, to ascertain ETT placement prior to confirmation by chest radiograph. Attempts at bridging the existing gaps in our knowledge with regard to neonatal noninvasive CO 2 monitoring can pave the way for its optimal utility in the management of critically ill newborn infants. Furthermore, accurate interpretation of these non-invasive measurements along with astute clinical assessments can expedite evaluation and diagnosis, and lead to swift stabilization and improved outcomes in neonates.

Association between oxygen saturation targeting and death or disability in extremely preterm infants in the neonatal oxygenation prospective metaanalysis collaboration

Oxygen saturation targets in preterm infants and outcomes at 18-24 months: a systematic review

Carbon dioxide and brain injury in preterm infants

The association between carbon dioxide, cerebral blood flow, and autoregulation in the premature infant

Both extremes of arterial carbon dioxide pressure and the magnitude of fluctuations in arterial carbon dioxide pressure are associated with severe intraventricular hemorrhage in preterm infants

Capnometry and anaesthesia

The first years of clinical capnography

Methods of gas analysis. Haldane method of gas analysis. London: Charles Griffin and Company

Ultralow gas concentration infrared absorption spectroscopy

A new type of secondary radiation

Dedicated monitoring of anesthetic and respiratory gases By Raman scattering

Über eine neue methode der registrierenden gasanalyse mit hilfe der absorption ultraroter strahlen ohne spektrale zerlegung

The capnogram as a guide to the efficacy of cardiac massage

Mastering infra-red capnography

ASA adopts basic monitoring standards

Methods of measurement of blood and gas carbon dioxide during anesthesia

Carbon dioxide tension and perfusion in the tissue

Transcutaneous analysis of arterial PCO 2

A combined transcutaneous PO 2 -PCO 2 electrode with electrochemical HCO 3 -stabilization

Transcutaneous PCO 2 electrode design with internal silver heat path

StatPearls Publishing Copyright © 2020

Carbon dioxide transport and carbonic anhydrase in blood and muscle

Defining segments and phases of a time capnogram

Capnography outside the operating rooms

End-tidal carbon dioxide monitoring in pediatric emergencies

Capnography in spontaneously breathing preterm infants with bronchopulmonary dysplasia

Capnography Outside the Operating Rooms

A novel method of distal end-tidal CO 2 capnography in intubated infants: comparison with arterial CO 2 and with proximal mainstream end-tidal CO 2

Current limitations of volumetric capnography in surfactant-depleted small lungs

Accuracy of a new low-flow sidestream capnography technology in newborns: a pilot study

Assessment of sidestream end-tidal capnography in ventilated infants on the neonatal unit

Comparing the novel microstream and the traditional mainstream method of end-tidal CO 2 monitoring with respect to PaCO 2 as gold standard in intubated critically ill children

Diagnostic accuracy of capnography during high-frequency ventilation in neonatal intensive care units

A system for monitoring pulmonary ventilation

Transcutaneous measurement of carbon dioxide tension during long-distance transport of neonates receiving mechanical ventilation

Transcutaneous carbon dioxide monitoring during high-frequency oscillatory ventilation in infants and children

Discrepancies between transcutaneous and end-tidal carbon dioxide monitoring in the critically ill neonate with respiratory distress syndrome

Combined transcutaneous oxygen, carbon dioxide tensions and end-expired CO 2 levels in severely ill newborns

Estimation of PaCO 2 by two noninvasive methods in the critically ill newborn infant

The design, use, and results of transcutaneous carbon dioxide analysis: current and future directions

Accuracy of transcutaneous CO 2 monitoring in newborns undergoing therapeutic hypothermia

Monitoring exhaled carbon dioxide

Efficacy of the FEF colorimetric end-tidal carbon dioxide detector in children

Pedi-cap color change precedes a significant increase in heart rate during neonatal resuscitation

Disposable colorimetric carbon dioxide detector use as an indicator of a patent airway during noninvasive mask ventilation

Endotracheal intubation attempts during neonatal resuscitation: success rates, duration, and adverse effects

Respiratory monitoring of neonatal resuscitation

Tidal volume threshold for colorimetric carbon dioxide detectors available for use in neonates. Pediatrics

Carbon dioxide detector

WITHDRAWN: techniques to ascertain correct endotracheal tube placement in neonates

Major complications of airway management in the UK: results of the fourth national audit project of the royal college of anaesthetists and the difficult airway society. Part 2: intensive care and emergency departments

American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care

Expired PCO 2 as an index of coronary perfusion pressure

Physiologic monitoring of CPR quality during adult cardiac arrest: a propensitymatched cohort study

Vasoparalysis associated with brain damage in asphyxiated term infants

Continuous end-tidal carbon dioxide monitoring during resuscitation of asphyxiated term lambs

Effect of CO 2 and 100% O 2 on cerebral blood flow in preterm infants

Incidence of hypo-and hypercapnia in a cross-sectional European cohort of ventilated newborn infants

Impact of continuous capnography in ventilated neonates: a randomized, multicenter study

Hypercapnia during the first 3 days of life is associated with severe intraventricular hemorrhage in very low birth weight infants

Effects of hypocarbia on the development of cystic periventricular leukomalacia in premature infants treated with high-frequency jet ventilation

Hypocarbia in the ventilated preterm infant and its effect on intraventricular haemorrhage and bronchopulmonary dysplasia

Relationship between PCO 2 and unfavorable outcome in infants with moderate-to-severe hypoxic ischemic encephalopathy

Do hyperoxaemia and hypocapnia add to the risk of brain injury after intrapartum asphyxia?

Disposable colorimetric carbon dioxide detector use as an indicator of a patent airway during noninvasive mask ventilation

Airway obstruction during mask ventilation of very low birth weight infants during neonatal resuscitation

Airway obstruction and gas leak during mask ventilation of preterm infants in the delivery room

Exhaled carbon dioxide can be used to guide respiratory support in the delivery room

Short-and intermediate-term outcomes of preterm infants receiving positive pressure ventilation in the delivery room

international consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations

A review of carbon dioxide monitoring in preterm newborns in the delivery room

Pediatric life support: 2020 international consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations

Textbook of neonatal resuscitation

The pediatric disposable end-tidal carbon dioxide detector role in endotracheal intubation in newborns

Are carbon dioxide detectors useful in neonates?

The use of capnography for recognition of esophageal intubation in the neonatal intensive care unit

Use of capnography in the delivery room for assessment of endotracheal tube placement

Assessment of flow waves and colorimetric CO 2 detector for endotracheal tube placement during neonatal resuscitation

Neonatal abstinence syndrome after methadone or buprenorphine exposure

End-tidal carbon dioxide concentration during cardiopulmonary resuscitation

Part 1: executive summary: 2020 American heart association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care

Continuous capnography monitoring during resuscitation in a transitional large mammalian model of asphyxial cardiac arrest

Respiratory monitors to teach newborn facemask ventilation: a randomised trial

Quantitative end-tidal carbon dioxide monitoring in the delivery room: a randomized controlled trial

Delivery room end tidal CO2 monitoring in preterm infants <32 weeks

Impact of continuous capnography in ventilated neonates: a randomized, multicenter study

Mainstream end-tidal carbon dioxide monitoring in ventilated neonates

End tidal carbon dioxide monitoring-its reliability in neonates

Agreement of carbon dioxide levels measured by arterial, transcutaneous and end tidal methods in preterm infants < or = 28 weeks gestation

Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life?

Mainstream end-tidal carbon dioxide monitoring in the neonatal intensive care unit

Detection of carbon dioxide thresholds using low-flow sidestream capnography in ventilated preterm infants

Monitoring of end tidal carbon dioxide and transcutaneous carbon dioxide during neonatal transport

Hypoxic and hypercapnic ventilatory responses in awake children with congenital central hypoventilation syndrome

Poor performance of mainstream capnography in newborn infants during general anesthesia

Paediatric intensive care and neonatal intensive care airway management in the United Kingdom: the PIC-NIC survey

Current limitations of volumetric capnography in surfactant-depleted small lungs

Volumetric capnography in infants with bronchopulmonary dysplasia

Technical and clinical aspects of capnography in neonates

Confirmation of correct tracheal tube placement in newborn infants

Effect of lung hypoplasia on birthrelated changes in the pulmonary circulation in sheep

False-positive results on colorimetric carbon dioxide analysis in neonatal resuscitation: potential for serious patient harm

Accuracy of transcutaneous carbon dioxide measurement in premature infants

Effects of the transcutaneous electrode temperature on the accuracy of transcutaneous carbon dioxide tension

Effect of transcutaneous electrode temperature on accuracy and precision of carbon dioxide and oxygen measurements in the preterm infants

The authors would like to thank the funding sources listed below.

DS conceptualized, designed, drafted the initial manuscript, reviewed, and revised the manuscript. LZ, SI, PC, and SL contributed to the concept, reviewed, and revised the manuscript. All the authors have critically revised and approved the final version of the manuscript. All authors agree to be accountable for all aspects of the work. 

The authors declare no competing interests.

Correspondence and requests for materials should be addressed to D.S.

Publisher's note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.